The unexpected benefits of Mounjaro people don't always talk about

Does Mounjaro improve blood pressure and cholesterol as well?

In the SURMOUNT-1 trial, published in the New England Journal of Medicine, researchers tracked a range of cardiometabolic markers alongside body weight. At 72 weeks, participants on the highest doses saw average reductions in systolic blood pressure of around 6–7 mmHg and meaningful falls in triglycerides and LDL cholesterol. These weren't people being treated specifically for those conditions. They were people taking tirzepatide for weight management, and the improvements appeared to follow the weight loss, though the drug's direct effects on glucose and lipid metabolism may also play a role.

Blood pressure is one of the things our prescribers hear patients mention unprompted: a GP appointment six months into treatment, readings that have quietly normalised. It doesn't happen for everyone, and no clinician will promise it. But it is documented, and it matters, because cardiovascular risk doesn't move in one place at a time.

For a fuller picture of what weight reduction typically looks like on tirzepatide, our tirzepatide expected weight loss page covers the trial evidence in detail.

What about blood sugar, even if you don't have diabetes?

Tirzepatide was originally developed as a diabetes medicine and is still licensed for type 2 diabetes, so its effects on blood glucose are well-documented. Less discussed is what happens in people who start treatment with prediabetes or insulin resistance without a formal diagnosis.

In SURMOUNT-1, a meaningful proportion of participants who had prediabetes at baseline saw their blood sugar return to the normal range during the trial. This is significant because prediabetes often sits quietly in the background (no symptoms, no treatment) while gradually increasing the risk of cardiovascular disease and type 2 diabetes itself. Improving insulin sensitivity through weight loss, reduced liver fat, and tirzepatide's direct action on GIP and GLP-1 pathways may be doing real preventive work, even in people who would never describe themselves as diabetic.

The NICE appraisal of tirzepatide (TA1026) acknowledges these broader metabolic effects as part of its assessment of clinical value.

Can Mounjaro help with sleep apnoea or joint pain?

This is where it gets interesting, and honest. There is no evidence that tirzepatide directly treats obstructive sleep apnoea or osteoarthritis. What there is evidence for is that both conditions are significantly worsened by excess weight, and that reducing weight by 15–20% can produce substantial improvements in both.

People carrying weight around the neck and chest often find that sleep quality improves noticeably as that weight comes down. The pressure on joints (knees especially) reduces in a roughly mechanical way: less load, less pain, better range of movement. Some people say this is the change they feel first, before they've even noticed the scale moving. That's not a drug effect in the pharmacological sense; it's the downstream reward of losing weight in a body that was carrying too much of it.

If you want a sense of what the early weeks feel like before these broader changes settle in, what to expect in week two of Mounjaro gives a grounded account of the adjustment period.

Are there mental health or mood benefits people notice?

This is a question our prescribers hear often, and the honest answer is: it's complicated. Some people report improvements in mood, confidence, and relationship with food that feel significant. Others don't notice any change in mental wellbeing, or find the early gastrointestinal side effects temporarily affect how they feel day-to-day.

There is ongoing research into GLP-1 receptor agonists and neurological effects, but it is preliminary. What we can say is that for many people, the experience of clothes fitting differently, moving more easily, sleeping better, or seeing improved blood results has a real psychological effect. That's not trivial, it feeds motivation, consistency, and the long-term lifestyle changes that make treatment worthwhile.

Keep the pen in the fridge door where you'll see it each morning; that small visual cue helps, too. Routine matters more than most people expect.

None of this replaces a clinical conversation, and if you'd like a clear overview of the journey ahead, the Mounjaro what to expect page outlines the licensed use and what the consultation process looks like. If you're weighing up whether tirzepatide is right for your situation, speaking to our prescribers is the straightforward next step, no referral needed, free consultation, reviewed the same day by a real clinician.

Treatment costs are also worth understanding before you start, and our Mounjaro prices page sets out what to expect alongside our guide to Mounjaro expected weight loss, which walks through the evidence on how much weight people typically lose across the dose escalation period. If you'd prefer to read more broadly about the experience of starting treatment, what to expect from Mounjaro covers everything from the first injection to the longer-term picture.